Susan E. Graf

Susan E. Graf

DirectoratAardvark Therapeutics· In proxies 2024–2025

Susan E. Graf sits on 6 public boards.

Boards2

  • CG OncologyDirector · 2 yr on the boardIndependentAudit (Chair), Nominating and Corporate Governance—Paid as an executive
  • Aardvark TherapeuticsDirector · 1 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Aardvark TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role -89%
  2. CG OncologyPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Aardvark TherapeuticsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. KaléoPublic company
    • Director? – PresentNo stock prices for these years
  5. Finch TherapeuticsPublic company · 3 yr
    • Director2021 – 2024 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?